Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

908 Devices inflates IPO to $150m

908 Devices inflates IPO to $150m

Dec 28, 2020 • Robert Lavine

The chemical analysis device developer has added $20m to an initial public offering following $70m in funding from investors including Saudi Aramco and Schlumberger.

908 Devices, the US-based mass spectrometer provider backed by oil and gas supplier Saudi Aramco and oilfield services provider Schlumberger, has closed its initial public offering at approximately $150m.

The company issued 6.5 million shares priced at $20.00 each to raise an initial $130m earlier this month. Its shares opened at $45.51 on their first day of trading and opened at $72.00 this morning.

Lead book-running managers Cowen and SVB Leerink and book-running managers William Blair and Stifel subsequently took up the option to buy another 975,000 shares.

Founded in 2012, 908 has developed handheld and desktop mass spectrometer devices that analyse the chemical make-up of materials and substances.

The company secured a total of $70m pre-IPO, from Schlumberger, Saudi Aramco unit Saudi Aramco Energy Ventures, University of Tokyo Edge Capital, Arch Venture Partners, Razor’s Edge Ventures, Tao Capital Partners, Cormorant Asset Management, Casdin Capital, Sans Capital Ventures and Northpond Ventures.

908’s largest shareholders now the offering is closed are Arch Venture Partners, with a 20% stake, Razor’s Edge Ventures (7.2%), Saudi Aramco Energy Ventures (4.6%) and University of Tokyo Edge Capital (4.4%).

Robert Lavine

Robert Lavine is special features editor for Global Venturing.

The chemical analysis device developer has added $20m to an initial public offering following $70m in funding from investors including Utec.

908 Devices, the US-based mass spectrometer provider backed by University of Tokyo Edge Capital (Utec), has closed its initial public offering at approximately $150m.
The company issued 6.5 million shares priced at $20.00 each to raise an initial $130m earlier this month. Its shares opened at $45.51 on their first day of trading and opened at $72.00 this morning.
Lead book-running managers Cowen and SVB Leerink and book-running managers William Blair and Stifel subsequently took up the option to buy another 975,000 shares.
Founded in 2012, 908 has developed handheld and desktop mass spectrometer devices that analyse the chemical make-up of materials and substances.
The company secured a total of $70m pre-IPO from Utec, oilfield services provider Schlumberger, oil and gas supplier Saudi Aramco unit Saudi Aramco Energy Ventures, Arch Venture Partners, Razor’s Edge Ventures, Tao Capital Partners, Cormorant Asset Management, Casdin Capital, Sans Capital Ventures and Northpond Ventures.
908’s largest shareholders now the offering is closed are Arch Venture Partners, with a 20% stake, Razor’s Edge Ventures (7.2%), Saudi Aramco Energy Ventures (4.6%) and Utec (4.4%).
– A version of this article first appeared on our sister site, Global Corporate Venturing.
 

LEADERSHIP SOCIETY

Informing, connecting, and transforming the global corporate venture capital ecosystem.
The Global Corporate Venturing (GCV) Leadership Society’s mission is to help bridge the different strengths and ambitions of investors across industry sectors, geography, structure, and their returns.
Events
CVC Board Members & Board Observers
Nov 17 -
Nov 19, 2025
Live Online
Events
CVC Board Members and Board Observers
Dec 3 -
Dec 4, 2025
New York, USA
Events
Capturing CVC Performance with 'End-to-End' Investing KPIs
Dec 3 -
Dec 3, 2025
Online
Events
CVC Investment Programs
Feb 3 -
Mar 4, 2026
Live Online
Events
GCVI Summit 2026
Mar 24 -
Mar 26, 2026
Monterey, CA (USA)
Events
GCV Symposium 2026
Jun 23 -
Jun 24, 2026
London (UK)
© 2025 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here